Concepedia

John J. Orloff

JJ

29

Publications

5.3K

Citations

22

H-Index

1989

Active since

Affiliations

Veterans Health Administration(Current)

VA Connecticut Research and Education Foundation

Novartis (United States)

Yale University

Department of Veterans Affairs

John J. Orloff is an author at Veterans Health Administration specializing in medicine, signal transduction, and cell signaling.

Top concepts

Publications per year

1989–2013

29

Publications

29

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

Kenneth W. Lyles, Cathleen Colón‐Emeric, Jay Magaziner et al. · New England Journal of Medicine · 2007 · 2K citations · Full text

New and Emerging Etiologies for Community-Acquired Pneumonia with Implications for Therapy

Guodong Fang, Michael J. Fine, John J. Orloff et al. · Medicine · 1990 · 905 citations

Immunochemical Characterization of Circulating Parathyroid Hormone–Related Protein in Patients with Humoral Hypercalcemia of Cancer

William J. Burtis, T.G. Brady, John J. Orloff et al. · New England Journal of Medicine · 1990 · 561 citations · Full text

Change in Bone Turnover and Hip, Non-Spine, and Vertebral Fracture in Alendronate-Treated Women: The Fracture Intervention Trial

Douglas C. Bauer, Dennis M. Black, Patrick Garnero et al. · Journal of Bone and Mineral Research · 2004 · 408 citations · Full text

Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.

Thomas J. Schnitzer, Henry G. Bone, G Crepaldi et al. · PubMed · 2000 · 299 citations

, , +12

Rows per page

1–5 of 29